BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Pozen, Inc. 

6330 Quadrangle Drive, Suite 240

Chapel Hill  North Carolina  27514  U.S.A.
Phone: 919-490-0012 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Pozen, Inc. (POZN) Submits Final Study Report For PA8140/PA32540 Phase 1 Study On Schedule 4/2/2014 8:32:57 AM    More...
Pozen, Inc. (POZN) To Present At The ROTH Capital Partners 26th Annual Growth Stock Conference 3/4/2014 8:15:13 AM    More...
Pozen, Inc. (POZN) Announces March 5th Webcast Of Fourth Quarter And Year End 2013 Results 2/26/2014 7:23:22 AM    More...
Pozen, Inc. (POZN) Announces Appointment Of Dennis Mcnamara To Senior Vice President And Chief Business Officer 1/2/2014 6:29:22 AM    More...
Pozen, Inc. (POZN) Announces New PA8140/PA32540 PDUFA Date Of April 25, 2014 12/23/2013 9:21:43 AM    More...
Pozen, Inc. (POZN) Announces Special Cash Distribution 11/22/2013 9:19:07 AM    More...
Pozen, Inc. (POZN) to Present At The Piper Jaffray 25th Annual Healthcare Conference 11/21/2013 7:50:44 AM    More...
Pozen, Inc. (POZN) Announces September 5th Webcast to Discuss the PA8140/PA32540 Exclusive U.S. License Agreement 9/5/2013 9:19:28 AM    More...
Sanofi (France) (SAN.PA), Pozen, Inc. (POZN) Sign Exclusive Pact for Commercialization of Aspirin Products; POZN Stock Rises +10.59% at Market Close (September 5, 2013) 9/5/2013 7:07:19 AM    More...
Pozen, Inc. (POZN) to Host Analyst and Investor Update Webcast 4/10/2013 9:42:37 AM    More...
12345678910...